Juan C. Jaen, President at Arcus Biosciences, Inc. (RCUS), sold 13,950 shares at $20.09 ($280K) on 2024-01-02, disclosed to the SEC on 2024-01-04.
Scheduled sale ($280k) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.09 | 6,975 | $140K | 50.0% |
| 2 | $20.09 | 6,975 | $140K | 50.0% |
| Total | $20.09 avg | 13,950 | $280K | 100% |
| Filing → |
| RCUS | SELL | 2026-01-07 | $681K | — | Filing → |
| RCUS | SELL | 2025-12-18 | $688K | — | Filing → |
| RCUS | SELL | 2025-12-05 | $4.1M | — | Filing → |